The pathogenic mechanism of TIO is the excessive secretion of fibroblast growth factor 23 (FGF-23), a phosphatonin secreted by the tumor arising from mesenchymal tissue, which can result in reduced renal phosphate reabsorption and impaired vitamin D 1α-hydroxylase activity [1, 9]. Here, FGF23 is linked to neoplasm.